UBS Group’s RXO RXO Stock Holding History

UBS Group’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,100	Closed	-$311K	–	10268
2022 Q4	$311K	Buy	+18,100	New	+$321K	﹤0.01%	5085

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's RXO Position: Q1 2026 in Review

UBS Group increased its RXO (RXO) stake by 39% in Q1 2026, buying an estimated $8.77M and bringing the position to 2,117,291 shares worth $31M. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

UBS Group first reported a position in RXO in Q4 2022 and has held it in 14 quarters since. The position peaked at $45.4M in Q4 2024. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

UBS Group held 2,117,291 shares of RXO worth $31M as of Q1 2026.
UBS Group bought 597,641 RXO shares in Q1 2026, an estimated $8.77M.
RXO made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2137 holding.
UBS Group first reported a position in RXO in Q4 2022 and has held it in 14 quarters since.
UBS Group's RXO position peaked at $45.4M in Q4 2024.
275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.